eQTL analysis of significant SNPs. by Dai Nogimura (21445649)

Subjects:

Significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Results of the mediation model test for the elevated inhibition function in the relationship between elevated mindfulness level and decreased mobile phone addiction index. by Jizhao Li (5856650)

Temporal trend of ∑DDT levels in osprey eggs in different study areas and all areas combined (lower graph). by Matti Viluksela (321291)

Subjects:

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

MPA does not cause significant apoptosis effect in CN and CO. by Intan Sofia Omar (10451088)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Suggestive significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Virus from obese mice decreased infectivity to mosquitoes and lower transmission rates. by James Weger-Lucarelli (603766)

The contour-enhanced funnel plot demonstrated that the effect estimates were in both significant (<i>P</i> < 1%, 1% < <i>P</i> < 5%) and non-significant areas (5% < <i>P</i> < 10%,... by Polrat Wilairatana (50854)

Subjects:

Comparison of questionnaire scores among genotypes for the significant associations. by Dai Nogimura (21445649)

Subjects:

Results from the logistic regression of multimorbidity for adults aged 35 and above allowing significant interactions. by Xiang Xiao (44417)

Odds ratios for confirmed markers of transfusion-transmitted infectious diseases in blood and its component donations in Lithuania: A comparison between pandemic years. by Vytenis Kalibatas (14123877)

Subjects:

Number of blood and blood components’ donations in Lithuania between April 2019 and March 2023. by Vytenis Kalibatas (14123877)

Subjects:

Blood and its components donors’ deferrals in Lithuania between April 2019 and March 2023. by Vytenis Kalibatas (14123877)

Subjects:

Number of blood and its components’ donations according to specific dimensions in Lithuania between April 2019 and March 2023. by Vytenis Kalibatas (14123877)

Subjects:

The prevalence of confirmed transfusion-transmitted infectious disease markers in blood and its components’ donations in Lithuania between April 2019 and March 2023. by Vytenis Kalibatas (14123877)

Subjects:

Number of donations according to donors’ age and sex in Lithuania between April 2019 and March 2023. by Vytenis Kalibatas (14123877)

Subjects:

Odds ratios for confirmed transfusion-transmitted infectious disease markers in blood and its components’ donations: Comparison the pre-pandemic year with the pandemic years. by Vytenis Kalibatas (14123877)

Subjects: